Novel oral anticoagulants in the management of coronary artery disease

SR McMahon, K Brummel-Ziedins… - Coronary Artery …, 2016 - journals.lww.com
Despite advances in interventional and pharmacologic therapy, survivors of myocardial
infarction remain at an increased risk of subsequent cardiovascular events. Initial …
被引用次数：7 相关文章

Novel oral anticoagulants in the management of coronary artery disease.

SR McMahon, K Brummel-Ziedins… - Coronary Artery …, 2016 - europepmc.org
Despite advances in interventional and pharmacologic therapy, survivors of myocardial
infarction remain at an increased risk of subsequent cardiovascular events. Initial …

Novel oral anticoagulants in the management of coronary artery disease

SR McMahon, K Brummel-Ziedins… - Coronary artery …, 2016 - pubmed.ncbi.nlm.nih.gov
Despite advances in interventional and pharmacologic therapy, survivors of myocardial
infarction remain at an increased risk of subsequent cardiovascular events. Initial …

Novel oral anticoagulants in the management of coronary artery disease

SR McMahon, K Brummel-Ziedins… - Coronary Artery …, 2016 - ingentaconnect.com
Despite advances in interventional and pharmacologic therapy, survivors of myocardial
infarction remain at an increased risk of subsequent cardiovascular events. Initial …